Our COVID-19 safety protocols include universal screening, mandatory use of masks, physical distancing, and a strict no-visitor policy with exceptions only for medical necessity and pediatric patients under 18. To learn more about what we are doing to keep everyone safe during an in-office visit, click here.
Atrial Fibrillation (AFib) can happen to anyone. AFib is an irregular heartbeat or a condition in which the heart muscles fail to contract in a strong, rhythmic way. When a heart is in AFib, it may not be pumping enough oxygen-rich blood out to the body. People who have AFib with no symptoms have an increased risk of stroke. Hybrid ablation is a minimally invasive treatment for persistent AFib that combines surgical and catheter-based techniques. SMG’s Dr. Robert Altman, Director of Clinical Cardiac Electrophysiology, and Dr. Jonathan Steinberg, Director of the Arrhythmia Center, brought the procedure to Hackensack University Medical Center, the only facility in the state to offer the innovative technique. The SMG physicians, along with a patient who has had successful outcomes from hybrid ablation, spoke to NJTV about how the procedure could be a game-changer for individuals with AFib, particularly in patients who are difficult to treat.